Skip to main content
Clinical Trials/JPRN-UMIN000041583
JPRN-UMIN000041583
Completed
未知

A prospective observational study to evaluate the detection rate of actionable mutations by liquid biopsy Guardant360 in patients with non-squamous non-small cell lung cancer (NSCLC) whose gene alterations are not detected by tissue-based singleplex assays. (WJOG13620L) - A prospective observational study by G360 in NSCLC patients whose gene alterations are not deteted by tissue-based singleplex assays. (WJOG13620L)

West Japan Oncology Group0 sites72 target enrollmentAugust 31, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
West Japan Oncology Group
Enrollment
72
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2020
End Date
January 24, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Multiple cancer with metastasis. 2\) Severe psychological disease. 3\) Not fit for this trial judged by the doctor in charge.

Outcomes

Primary Outcomes

Not specified

Similar Trials